p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor
暂无分享,去创建一个
A. Ullrich | M. Winget | H. Shepard | A Ullrich | G. Lewis | B. Fendly | R. Hudziak | M Winget | B M Fendly | R M Hudziak | G D Lewis | H M Shepard | Axel ULLRICHlt
[1] R. Snyderman,et al. Do macrophages destroy nascent tumors? , 1979, Journal of the National Cancer Institute.
[2] K. Semba,et al. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Povey,et al. Identity of some human bladder cancer cell lines , 1983, Nature.
[4] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[5] A. Elbein,et al. Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate Glc-NAc-1-phosphate transferase. , 1979, Biochemistry.
[6] J. Yokota,et al. Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. , 1987, Cancer research.
[7] A. Ullrich,et al. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[8] M. Kraus,et al. Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms. , 1987, The EMBO journal.
[9] J. Mendelsohn,et al. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[10] N. Nomura,et al. Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor , 1986, Nature.
[11] P. Seeburg,et al. Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. , 1985, Science.
[12] A. Ullrich,et al. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing , 1987, Cell.
[13] C. Oliver,et al. A clonal derivative of tunicamycin‐resistant Chinese hamster ovary cells with increased N‐acetylglucosamine‐phosphate transferase activity has altered asparagine‐linked glycosylation , 1987, Journal of cellular physiology.
[14] B. Beutler,et al. Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.
[15] M. Greene,et al. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo. , 1988, Oncogene.
[16] M. Greene,et al. Monoclonal antibodies reactive with distinct domains of the neu oncogene-encoded p185 molecule exert synergistic anti-tumor effects in vivo. , 1988, Oncogene.
[17] C R King,et al. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.
[18] R. Weinberg,et al. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. , 1985, Science.
[19] H. Shepard,et al. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Ullrich,et al. Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. T. Lipari,et al. Epidermal growth factor receptor tyrosine kinase phosphorylation of glucose-6-phosphate dehydrogenase in vitro. , 1987, Archives of biochemistry and biophysics.
[22] R. Philip,et al. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1 , 1986, Nature.
[23] H. Schreiber,et al. Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity , 1983, The Journal of experimental medicine.
[24] Robert A. Weinberg,et al. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies , 1985, Cell.
[25] P. Leder,et al. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene , 1988, Cell.
[26] B. Aggarwal,et al. Effects of growth factors on the antiproliferative activity of tumor necrosis factors. , 1987, Cancer research.
[27] K. Rajewsky,et al. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. , 1979, Journal of immunology.
[28] A. Ullrich,et al. Growth factor receptor tyrosine kinases. , 1988, Annual review of biochemistry.
[29] S. Singer,et al. Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Sato,et al. [6] Derivation and assay of biological effects of monoclonal antibodies to epidermal growth factor receptors , 1987 .
[31] M. Yoshida,et al. Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line , 1986, Molecular and cellular biology.
[32] G. Nakamura,et al. Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells , 1984, Journal of virology.
[33] N. Nomura,et al. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. , 1988, Oncogene.
[34] M. J. van de Vijver,et al. Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene , 1987, Molecular and cellular biology.
[35] J. Mendelsohn,et al. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. , 1983, Molecular biology & medicine.
[36] B. Aggarwal,et al. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.
[37] C R King,et al. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. , 1985, Science.
[38] A. Ullrich,et al. Molecular analysis of signal transduction by growth factors. , 1988, Biochemistry.
[39] J. Vilček,et al. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[40] E. Engleman,et al. Production of functional human T-T hybridomas in selection medium lacking aminopterin and thymidine. , 1982, Proceedings of the National Academy of Sciences of the United States of America.